United Kingdom In Vitro Fertilization (IVF) Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The United Kingdom In Vitro Fertilization (IVF) Market is Segmented by Product Type (Reagent and Instrument) and End-User (Fertility Clinics, Hospitals, and Other End-Users). The report offers the value (in USD) for the above segments.

United Kingdom In Vitro Fertilization (IVF) Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

UK In Vitro Fertilization Market Size

UK In Vitro Fertilization Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
Historical Data Period 2019 - 2023
CAGR 7.60 %
Market Concentration Medium

Major Players

UK In Vitro Fertilization Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of UK In Vitro Fertilization Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

UK In Vitro Fertilization Market Analysis

The UK In Vitro Fertilization Market is expected to register a CAGR of 7.6% during the forecast period.

  • During the initial phases of the COVID-19 pandemic, many IVF clinics in the United Kingdom temporarily suspended their services or rescheduled non-urgent procedures. This was primarily due to prioritizing resources for COVID-19 patients, reducing the risk of virus transmission, and adhering to government-imposed restrictions. For instance, according to the article published by the National Center for Biotechnology Information (NCBI) in March 2021, the IVF treatment procedures were postponed from April to June months of the pandemic in the United Kingdom. Therefore, the postponement of IVF procedures significantly impacted the market growth initially. However, with the decrease in COVID-19 cases and the uplifting of lockdown restrictions in the country, the IVF market in the country picked up a significant pace and is expected to do the same during the forecast period.
  • The major factors driving the market growth include the rising success rate of IVF technology, increasing awareness about IVF procedures, and delayed onset of pregnancy. In addition, the rising number of patients undergoing IVF treatment is also projected to augment market growth during the forecast period. For instance, according to the data released by the Human Fertilisation & Embryology Authority (HFEA) in June 2023, approximately 55,000 patients underwent IVF or donor insemination (DI) treatment at HFEA-licensed fertility centers in the United Kingdom in 2021. Therefore, this substantial number of patients seeking fertility treatments highlights the country's growing demand for assisted reproductive technologies. With advancements in medical technology, increasing awareness, and changing societal trends, the United Kingdom IVF market is poised for growth. This will likely lead to an expansion of fertility centers and the development of innovative treatments to cater to the rising demand, ultimately driving market growth. Furthermore, the surging government initiatives in the United Kingdom are also projected to drive market growth during the forecast period.
  • For instance, in July 2022, the Government of the United Kingdom established the Women's Health Strategy in England to tackle the gender health gap, which is likely to drive the growth of the country's IVF market. The strategy aims to address the gender health gap and improve women's reproductive health and access to fertility treatments. By prioritizing women's health and reproductive rights, government regulation is expected to increase awareness and funding for IVF treatments. This could lead to improved accessibility and affordability of IVF services, encouraging more individuals and couples to seek fertility treatments. Consequently, the demand for IVF is likely to increase, driving the growth of the IVF market in the country.
  • Therefore, factors such as the rising number of IVF procedures and surging government initiatives to support IVF in the country are expected to drive market growth during the forecast period. However, social stigma and ethical and legal issues associated with in vitro fertilization are estimated to hinder the market growth during the forecast period.

UK In Vitro Fertilization Industry Overview

The United Kingdom In Vitro Fertilization (IVF) market is moderately consolidated due to a limited number of companies that manufacture and distribute IVF products. The competitive landscape includes analyzing companies that hold notable market shares and are well known, including Vitrolife, CooperSurgical, Inc., Merck KGaA, IBSA Pharma Ltd, and Ferring Pharmaceuticals Ltd, among others.

UK In Vitro Fertilization Market Leaders

  1. Vitrolife

  2. CooperSurgical, Inc.

  3. Merck KGaA

  4. IBSA Pharma Ltd

  5. Ferring Pharmaceuticals Ltd

  6. *Disclaimer: Major Players sorted in no particular order
UK In Vitro Fertilization Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

UK In Vitro Fertilization Market News

  • October 2022: TMRW Life Sciences, Inc. launched an advanced fertility specimen cryostorage facility to deliver a new standard of care directly to patients and fertility clinic partners in various countries, including the United Kingdom.
  • August 2022: FutureLife expanded its footmark in the United Kingdom by partnering with the Centre for Reproductive and Genetic Health (CRGH), an IVF clinic located in Central London. This partnership will support the strategic development of CRGH through continual innovation and enhance patient care with the use of FutureLife's IVF products.

Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Decrease in Fertility Rate in United Kingdom
    • 4.2.2 Increasing Adoption of IVF Procedures
    • 4.2.3 Favorable Government Regulations in the Country
  • 4.3 Market Restraints
    • 4.3.1 Social Stigma, Ethical, and Legal Issues Associated with In Vitro Fertilization
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value-USD)

  • 5.1 By Product
    • 5.1.1 Reagent
    • 5.1.2 Instrument
    • 5.1.2.1 Imaging Systems
    • 5.1.2.2 Incubators
    • 5.1.2.3 Cryosystems
    • 5.1.2.4 IVF Cabinet
    • 5.1.2.5 Ovum Aspiration Pump
    • 5.1.2.6 Sperm Separation Systems
    • 5.1.2.7 Micromanipulator Systems
    • 5.1.2.8 Other Instruments
  • 5.2 By End-User
    • 5.2.1 Fertility Clinics
    • 5.2.2 Hospitals
    • 5.2.3 Other End-Users

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Vitrolife
    • 6.1.2 CooperSurgical, Inc.
    • 6.1.3 Merck KGaA
    • 6.1.4 IBSA Pharma Ltd
    • 6.1.5 Ferring Pharmaceuticals Ltd
    • 6.1.6 Esco Medical UK Ltd
    • 6.1.7 Kitazato Corporation
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

UK In Vitro Fertilization Industry Segmentation

In vitro fertilization is an assistive reproductive technology that involves the process of fertilization by retrieving eggs from the woman's ovaries and fertilizing them with sperm outside of the body in a laboratory environment. 

The United Kingdom in vitro fertilization (IVF) market is segmented by product type (reagent and instrument ((imaging systems, incubators, cryosystems, IVF cabinet, ovum aspiration pump, sperm separation systems, micromanipulator systems, and other instruments)) and end-users (fertility clinics, hospitals, and other end-users).

The report offers the value (in USD) for the above segments.

By Product Reagent
Instrument Imaging Systems
Incubators
Cryosystems
IVF Cabinet
Ovum Aspiration Pump
Sperm Separation Systems
Micromanipulator Systems
Other Instruments
By End-User Fertility Clinics
Hospitals
Other End-Users
Need A Different Region or Segment?
Customize Now

Frequently Asked Questions

What is the current undefined size?

The undefined is projected to register a CAGR of 7.6% during the forecast period (2025-2030)

Who are the key players in undefined?

Vitrolife, CooperSurgical, Inc., Merck KGaA, IBSA Pharma Ltd and Ferring Pharmaceuticals Ltd are the major companies operating in the undefined.

What years does this undefined cover?

The report covers the undefined historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the undefined size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

UK In Vitro Fertilization Industry Report

Statistics for the 2025 UK In Vitro Fertilization market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. UK In Vitro Fertilization analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.

UK In Vitro Fertilization Market Report Snapshots